MOH — authorised 30 January 2009
- Marketing authorisation holder: TAKEDA PHARMS USA
- Status: likely_approved
MOH authorised Dexilant on 30 January 2009
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 30 January 2009.
TAKEDA PHARMS USA holds the Israeli marketing authorisation.